Page 746 in:
Title Manual of clinical oncology
Spiral manual
Manual of Clinical Oncology
Lippincott Manual Series
Authors Dennis Albert Casciato, Mary C. Territo
Editors Dennis Albert Casciato, Mary C. Territo
Contributor Mary C. Territo
Edition 6, illustrated
Publisher Lippincott Williams & Wilkins, 2008
0-7817-6884-5, 978-0-7817-6884-9
Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thurlimann, B; և այլք: (2006). «CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: A combined analysis of seven International Breast Cancer Study Group trials». Annals of Oncology. 18 (4): 701–8. doi:10.1093/annonc/mdl492. PMID17237474.
Bast RC, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB (1998). «CA 125: the past and the future». Int. J. Biol. Markers. 13 (4): 179–87. doi:10.1177/172460089801300402. PMID10228898.
Bagan P, Berna P, Assouad J, Hupertan V, Le Pimpec Barthes F, Riquet M (January 2008). «Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax». Eur. Respir. J. 31 (1): 140–2. doi:10.1183/09031936.00094206. PMID17804443.
Schneider, J; Peltri, G; Bitterlich, N; Philipp, M; Velcovsky, HG; Morr, H; Katz, N; Eigenbrodt, E (2003). «Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients». Clinical and Experimental Medicine. 2 (4): 185–91. doi:10.1007/s102380300005. PMID12624710.
Kumar, Yogesh; Tapuria, Niteen; Kirmani, Naveed; Davidson, Brian R. (2007). «Tumour M2-pyruvate kinase: A gastrointestinal cancer marker». European Journal of Gastroenterology & Hepatology. 19 (3): 265–276. doi:10.1097/MEG.0b013e3280102f78. PMID17301655.
Kaura, B; Bagga, R; Patel, FD (2004). «Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma». The Journal of Obstetrics and Gynaecology Research. 30 (3): 193–6. doi:10.1111/j.1447-0756.2004.00187.x. PMID15210041.
Leboeuf R, Langlois MF, Martin M, Ahnadi CE, Fink GD (February 2006). «"Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature». J. Clin. Endocrinol. Metab. 91 (2): 361–4. doi:10.1210/jc.2005-1429. PMID16278263.
genome.gov
Promoting Safe and Effective Genetic Testing in the United States genome.gov
Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thurlimann, B; և այլք: (2006). «CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: A combined analysis of seven International Breast Cancer Study Group trials». Annals of Oncology. 18 (4): 701–8. doi:10.1093/annonc/mdl492. PMID17237474.
Osman N, O'Leary N, Mulcahy E, Barrett N, Wallis F, Hickey K, Gupta R (September 2008). «Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre». Ir Med J. 101 (8): 245–7. PMID18990955.
Bast RC, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB (1998). «CA 125: the past and the future». Int. J. Biol. Markers. 13 (4): 179–87. doi:10.1177/172460089801300402. PMID10228898.
Bagan P, Berna P, Assouad J, Hupertan V, Le Pimpec Barthes F, Riquet M (January 2008). «Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax». Eur. Respir. J. 31 (1): 140–2. doi:10.1183/09031936.00094206. PMID17804443.
Lüftner, D; Mesterharm, J; Akrivakis, C; Geppert, R; Petrides, PE; Wernecke, KD; Possinger, K (2000). «Tumor type M2 pyruvate kinase expression in advanced breast cancer». Anticancer Research. 20 (6D): 5077–82. PMID11326672.
Benesch, C; Schneider, C; Voelker, HU; Kapp, M; Caffier, H; Krockenberger, M; Dietl, J; Kammerer, U; Schmidt, M (2010). «The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer». Anticancer Research. 30 (5): 1689–94. PMID20592362.
Oremek, GM; Sapoutzis, N; Kramer, W; Bickeböller, R; Jonas, D (2000). «Value of tumor M2 (Tu M2-PK) in patients with renal carcinoma». Anticancer Research. 20 (6D): 5095–8. PMID11326675.
Wechsel, HW; Petri, E; Bichler, KH; Feil, G (1999). «Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinase type M2 (Tu M2-PK)». Anticancer Research. 19 (4A): 2583–90. PMID10470199.
Schneider, J; Peltri, G; Bitterlich, N; Philipp, M; Velcovsky, HG; Morr, H; Katz, N; Eigenbrodt, E (2003). «Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients». Clinical and Experimental Medicine. 2 (4): 185–91. doi:10.1007/s102380300005. PMID12624710.
Oremek, G; Kukshaĭte, R; Sapoutzis, N; Ziolkovski, P (2007). «The significance of TU M2-PK tumor marker for lung cancer diagnostics». Klinicheskaia Meditsina. 85 (7): 56–8. PMID17882813.
Hardt, PD; Ngoumou, BK; Rupp, J; Schnell-Kretschmer, H; Kloer, HU (2000). «Tumor M2-pyruvate kinase: A promising tumor marker in the diagnosis of gastro-intestinal cancer». Anticancer Research. 20 (6D): 4965–8. PMID11326648.
Kumar, Yogesh; Tapuria, Niteen; Kirmani, Naveed; Davidson, Brian R. (2007). «Tumour M2-pyruvate kinase: A gastrointestinal cancer marker». European Journal of Gastroenterology & Hepatology. 19 (3): 265–276. doi:10.1097/MEG.0b013e3280102f78. PMID17301655.
Kaura, B; Bagga, R; Patel, FD (2004). «Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma». The Journal of Obstetrics and Gynaecology Research. 30 (3): 193–6. doi:10.1111/j.1447-0756.2004.00187.x. PMID15210041.
Ahmed, AS; Dew, T; Lawton, FG; Papadopoulos, AJ; Devaja, O; Raju, KS; Sherwood, RA (2007). «M2-PK as a novel marker in ovarian cancer. A prospective cohort study». European Journal of Gynaecological Oncology. 28 (2): 83–8. PMID17479666.
Leboeuf R, Langlois MF, Martin M, Ahnadi CE, Fink GD (February 2006). «"Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature». J. Clin. Endocrinol. Metab. 91 (2): 361–4. doi:10.1210/jc.2005-1429. PMID16278263.
Pastor A, Menéndez R, Cremades MJ, Pastor V, Llopis R, Aznar J (March 1997). «Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis». Eur. Respir. J. 10 (3): 603–9. PMID9072992.
